intermediate follow-up. Most patients undergoing mesh removal presented with pain in the presence of mesh erosion or exposure, but 28% reported pain in the absence of mesh exposure or erosion. This cohort also demonstrates coexisting psychiatric, immunosuppressive, and other chronic pain conditions that should be further investigated for impact on the development of mesh complications. Patients who do develop symptomatic pelvic floor mesh complications should be counseled on the option of surgical removal.
INTRODUCTION AND OBJECTIVES:
There is much data in the literature about the complications of vaginal mesh; however, there is much less addressing the clinical outcomes for patients who undergo vaginal mesh removal due to complications from their mesh. The objective of this study is to describe the clinical history leading up to as well as the outcomes after vaginal mesh removal surgery at an academic, tertiary care hospital.
METHODS: A retrospective study of patients who underwent vaginal mesh removal from 2008 to 2015. Demographics, clinical history, physical exam, pre-and post-operative symptoms, and number of re-operations were abstracted. Fisher 0 s exact test with significance at p<0.05 was used for comparative statistics.
RESULTS: Between February 2008 and November 2015, 84 patients underwent vaginal mesh removal at our hospital. The median time interval from initial mesh placement to removal was 58 months (range 0.4 to 154 months). Most patients (n¼61, 73%) had no prior history of mesh removal surgery. The most common pre-operative symptoms were vaginal pain (n¼52, 62%), dyspareunia (n¼ 46, 55%), and pelvic pain (n¼42, 50%). Intraoperative complications were infrequent with injury to the urethra, bladder, and bowel occurring in 1 patient each (n¼3, 4%). Of patients presenting for follow up within 4-6 weeks post-operatively, 45 (83%) were deemed better than before surgery. Pre-operative symptoms that improved by six weeks or greater following mesh removal surgery were mesh erosion (p<.0001), vaginal pain (p<.0001), vaginal bleeding (p¼0.0028), vaginal discharge (p¼0.0127), dyspareunia (p¼0.0024), and pelvic pain (p¼0.0005). There were no identifiable risk factors to predict which patients would have persistent post-operative symptoms or who would require more than one mesh removal surgery. After vaginal mesh removal, 29 patients (35%) required one or more re-operations with 3 being the highest number of reoperations.
CONCLUSIONS: Vaginal mesh removal surgery is safe and can alleviate many pre-operative symptoms. Some patients require more than one procedure and the risk factors for reoperations are unclear.
Source of Funding: None

PD17-11 LONG-TERM FOLLOW-UP OF ANTERIOR VAGINAL REPAIR: A COMPARISON AMONG COLPORRAPHY, COLPORRAPHY WITH REINFORCEMENT BY XENOGRAFT, AND MESH.
Matteo Balzarro*, Emanuele Rubilotta, Antonio Benito Porcaro, Nicolò Trabacchin, Sarti Alessandra, Maria Angela Cerruto, Salvatore Siracusano, Walter Artibani, Verona, Italy INTRODUCTION AND OBJECTIVES: The aim of our study was to assess the long-term efficacy, the outcomes, and the complications in patients treated for pelvic organ prolapse (POP) with transvaginal anterior colporrhaphy alone (AC), AC and reinforcement by porcine Xenograft (Pelvisoftâ) (AC-P), and AC and reinforcement by polypropylene mesh (AC-M). Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e357 METHODS: A retrospective analisis of a prospectively maintained database of women undergoing cystocele repair between 2000 and 2015 was performed. In a cohort of 123 women, the follow-up was completed in 109: 42 patients underwent AC, 19 AC-P, and 48 AC-M. Mean follow-up was 94.80 AE 51.72 months. Subjectives outcomes have been evaluated by validated questionnaires. The personal patient satisfaction rate was also measured by the questions "are you satisfied with the surgical procedure?" and "would you confirm the same surgical choice at the time of the counseling before surgery?". Objective outcomes have been evaluated considering a failure an anterior vaginal wall recurrence ¼ II POP-Q and 2 Baden-Walker Halfway System. RESULTS: In all the surgical techniques used the results of PGI-I questionnaire showed a general perceived benefit of treatment as well as the results of PPBC questionnaire indicated an improvement from the previous bladder condition. The personal patient's satisfaction rate was higher in the AC-P group. In all groups most of the interviewed women would confirm the same surgical choice. We find anatomical success rate > 80% in all groups with no statistically significant difference. Data showed a higher rate of complications in the AC-M group (p<0.05). Table  1 summarizes the characteristics of the patients, outcomes and complications. The larger number of complications in AC-M group (p<0.05) could explain the lower subjective satisfaction of patients.
CONCLUSIONS: Considering the recent FDA order to reclassify surgical mesh to class III, and the recent SCENHIR document on "Safety of surgical meshes used in urogynecological surgery" our data show in the AC group good results in a very long follow-up. The additional support given by a mesh, or a xenograft, does not increase with statistically significance the anatomic cure rate. Rather, the use of prosthetic devices leads more complications rate.
Source of Funding: none
PD17-12 TWENTY-YEAR EXPERIENCE WITH THE ANTERIOR VAGINAL WALL SUSPENSION PROCEDURE: A NATIVE TISSUE VAGINAL REPAIR FOR STRESS URINARY INCONTINENCE WITH EARLY STAGE ANTERIOR COMPARTMENT PROLAPSE
Alexander Rozanski*, Philippe Zimmern, Alana Christie, Feras Alhalabi, Dallas, TX INTRODUCTION AND OBJECTIVES: To report on the mid and long term outcomes for the anterior vaginal wall suspension (AVWS) procedure for stress urinary incontinence (SUI) with early stage anterior compartment prolapse.
METHODS: Following IRB approval, the long term prospective Access database of non neurogenic women who underwent AVWS for SUI and early stage anterior compartment prolapse was reviewed in women with complete pre and postoperative records and minimum 6 month follow up. Preoperative evaluation included detailed history, validated questionnaires (UDI 6, QoL), physical examination, and standing lateral voiding cystourethrogram (VCUG). Follow up included physical examination, questionnaires, and one VCUG at 6 to 12 months postoperatively. Failure was measured by Kaplan Meier curves using time to reoperation for incontinence as documented in the most recent patient encounter. Mixed effects model least square means were used for baseline versus post AVWS mean score comparison and for follow up period mean score comparison.
RESULTS: Between 1996 and 2016, 235 patients met inclusion criteria. Median follow up was 5.3 years, with 47 (20%) patients having over 10 year follow up. Mean SD were: age 62.0 (11.0), BMI 26.0 (6.4), and parity 2.4 (1.3). 104 (44%) patients underwent AVWS alone. Among concomitant procedures, hysterectomy (LAVH) was the most common. Aa and Ba points, questionnaire results, and QoL consistently improved postoperatively and remained improved over time (Table 1) . VCUG findings also improved for urethral support and cystocele reduction. Additional therapy was required in 12 (5%) patients, with sling placement (4) or injectable agents (8).
CONCLUSIONS: The AVWS procedure can durably correct SUI secondary to urethral hypermobility by restoration of anatomical support to the bladder neck and bladder base.
